Ryan Dietz

Vice President Corporate Development @Treadwell Therapeutics, Inc

Boston, MA, US

Senior business and corporate development leader for a multi-modality oncology and immunology biotech, supporting partnership strategy, transaction execution, and intellectual property positioning across a growing clinical and preclinical portfolio. Led global business development and corporate partnering strategy, sourcing and triaging ~50 annual partnering and investor opportunities through BIO and direct outreach Advanced partnering across three clinical-stage oncology programs, four preclinical antibody assets, and early-stage cell therapy platforms Drove cross-functional diligence and deal processes, translating scientific, clinical, and financial inputs into external partnership materials and term sheets Managed broad transactional portfolio including licensing agreements, MSAs, clinical trial agreements, and strategic vendor contracts Directed international intellectual property strategy across expanding preclinical and clinical asset portfolios Supported organizational scale from early-stage team to 50+ FTE across four global locations